Does Ultrasound Assessment for Extravascular Lung Water and IVC Measurement Affect Outcomes in Inpatient Heart Failure Management?
Does Serial Ultrasonographic Assessment for Extravascular Lung Water and IVC Measurement Affect Outcomes in Inpatient Heart Failure Management?
1 other identifier
interventional
400
1 country
1
Brief Summary
This study evaluates daily POCUS/FCU exams on patients admitted for acute decompensated heart failure with primary end point of acute kidney injury while in hospital.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2019
CompletedFirst Submitted
Initial submission to the registry
November 20, 2019
CompletedFirst Posted
Study publicly available on registry
June 18, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2021
CompletedJune 18, 2020
June 1, 2020
1.9 years
November 20, 2019
June 15, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Worsening renal failure
Serum Creatnine levels measured in mg/dL
During hospitalization typically one week
Secondary Outcomes (1)
Length of stay
During hospitalization typically one week
Study Arms (2)
Daily POCUS
EXPERIMENTALPatients are assessed by facility experts with daily chest ultrasound and findings of interstitial syndrome and IVC measurement are reported to primary care providers.
Usual care
NO INTERVENTIONPatients are assessed daily by primary care providers per usual care.
Interventions
Daily evaluation of lung ultrasound for B line artifacts plus IVC assessments
Eligibility Criteria
You may qualify if:
- Age \>18 admitted for acute decompensated heart failure exacerbation as primary admission diagnosis from Emergency department to General Medicine ward that are administered diuretic therapy expected to be admitted for two days or more.
You may not qualify if:
- Decline consent for study
- If admitted and research team not available for consent and initial evaluation prior within 6 hours of first diuretic administration
- Patients in whom diuretics will not be utilized (i.e. anuric, ESRD on HD)
- Inability to assess IVC (surgical anatomy, body habitus, Ileus, etc.)
- Patients admitted to ICU
- Patients currently on positive pressure ventilation (BiPAP)
- Patients discharged from the emergency department
- Patients discharged prior to evaluation by the POCUS team
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
RUHS Medical center
Moreno Valley, California, 92555, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Medical Program Director
Study Record Dates
First Submitted
November 20, 2019
First Posted
June 18, 2020
Study Start
August 1, 2019
Primary Completion
July 1, 2021
Study Completion
July 1, 2021
Last Updated
June 18, 2020
Record last verified: 2020-06
Data Sharing
- IPD Sharing
- Will not share